SUTRO BIOPHARMA, INC.
Biological Products, (No Diagnostic Substances) · 111 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA 94080
官方登記資料
0位追蹤者
2003成立於
關於 SUTRO BIOPHARMA, INC.
Sutro Biopharma, Inc. is a publicly traded biotechnology company headquartered in South San Francisco, California focused on clinical-stage drug discovery, development and manufacturing. Using a proprietary cell-free protein synthesis platform, Sutro is working on oncology therapeutics using protein engineering and rational design. Founded in 2003 under the name Fundamental Applied Biology, the company name changed to Sutro Biopharma in 2009. William Newell, CEO as of 2024, joined Sutro in January 2009.
Source: Wikipedia
產業Biological Products, (No Diagnostic Substances)
總部111 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA 94080
成立時間2003
法律形式C Corporation
狀態營運中
專利253 項專利
ANTI-B7-H3 ANTIBODIES, COMPOSITIONS COMPRISING ANTI-B7-H3 ANTIBODIES AND METHODS OF MAKING AND USING ANTI- B7-H3 ANTIBODIESWO2026165269A1 · 2026
HIGH CELL DENSITY FED-BATCH FERMENTATIONWO2026136953A3 · 2026
關鍵數據
法律資訊
| 法定名稱 | SUTRO BIOPHARMA, INC. |
|---|---|
| 法律形式 | C Corporation |
| SEC CIK | 1382101在 SEC EDGAR 上查看 ↗ |
| EIN | 45-2441988 |
| 產業代碼(SIC) | 2836 |
| 登記地址 | 111 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA 94080 |
| 狀態 | 營運中 |
來源: SEC EDGAR · 更新於 2026年10月15日
聯絡方式與連結
地點
111 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA 94080
這是你的公司嗎?
免費認領此頁面,即可新增標誌、產品、照片與職缺,並回覆評論。
認領此頁面